You may leave me a review on these links:
Our comprehensive pathway includes one-stop diagnostics, surgical referral, chemotherapy, radiotherapy and integrative care, such as exercise medicine.
Our centres provide a one-stop, triple assessment service for symptomatic patients using the latest digital mammography techniques.
Rapid access pathways:
If a patient is diagnosed with breast cancer, our advanced diagnostic modalities, including MRI breast and PET-CT scans, allow us to make decisions with the patient about potential treatment pathways and to start treatment promptly.
Treatment can often start within days of diagnosis. We assist with insurance approvals and funding queries to ensure patients have fast access and continuity of care. We are recognised by all insurers, and self-pay options are available.
Our one stop breast clinics provide a consultant-delivered service comprised of a consultant breast surgeon, supported by a dedicated on-site team of breast consultant radiologists, radiographers, clinical nurse specialists and healthcare assistants. This multidisciplinary team will support patients during their initial appointment and during any further visits to ensure a smooth transition from investigation to treatment if needed. The team have expert knowledge of local and regional cancer services and can provide practical guidance and emotional support according to individual needs.
All patients have full access to a one stop, triple assessment service, clinical examination, imaging test and biopsy where required. They will see a consultant breast surgeon and undergo mammography and ultrasound as necessary. The results of these tests will be discussed with the patient during the clinic visit. Should a biopsy be required, this will also be taken during the appointment, with the results available to patients five to ten days later.
If no biopsy is performed, the results will be discussed with the patient on the same day – before leaving the clinic.
To refer a patient to the one stop breast clinic, simply complete the interactive request form for the centre you wish to refer to, and send to the email address at the top of each form. For enquiries, please phone or email your chosen centre.
All mammography is undertaken using our state‑of-the-art digital mammography machines, allowing consultants to view the images immediately. Digital mammography also helps with a fast and accurate diagnosis as it enables our consultants to identify very small calcifications, which can be a sign of early cancerous change.
Digital breast tomosynthesis provides a 3D reconstruction of the breast which increases cancer detection and reduces false-positive findings compared to digital mammography.
Tomosynthesis (or 3D) mammography uses an x-ray tube that moves in an arc and takes low radiation dose projections of the breast from different angles.
These 3D images help to minimise the tissue overlap, which can hide cancers or make it difficult to distinguish normal overlapping breast tissue from tumours.
MRI is used where needed in addition to mammography and breast ultrasound. It has been shown to improve the detection of small breast lesions, particularly in younger women with dense breasts and for women with breast implants. The surgeon and radiologist will advise when when an MRI scan might be helpful.
If a biopsy is taken, the results will be made available at a follow up appointment with the consultant – this will take place within a week of the biopsy. A copy of these results is also shared with the patient’s GP.
All biopsy results are discussed at a Breast Multidisciplinary Team (MDT) meeting, which includes surgeons, radiologists, pathologists, and oncologists. Biopsy results are viewed alongside the clinical, mammogram and ultrasound investigations to ensure appropriate action is taken.
If no evidence of breast cancer is found, the results are discussed with the patient in detail, together with any advice or reassurances. If the biopsy does show a cancer, we will discuss with the patient the next steps required to move towards appropriate treatment.
Our pathways draw on the latest diagnostic modalities and genomic profiling techniques, providing our patients with an accurate prognosis and guiding treatment decisions around chemotherapy and endocrine therapy. We currently use validated predictive and prognostic tests such as:
We operate as multidisciplinary cancer care teams (MDTs). These teams include surgeons, radiologists, pathologists, and oncologists. The team reviews all biopsies and diagnostic imaging in order to agree an individualised treatment plan for every patient.
We work closely with leading local and regional surgeons and oncologists to provide complete rapid access pathways. GPs can refer for diagnostics directly or to a referring surgeon. The surgeons consult at private hospitals near our centres and have established referral pathways to the oncologists at GenesisCare.
Our Breast Clinical Reference Group support and oversee: